CK Life Sciences International (Holdings), Inc. (0775.HK) AI-Powered Stock Analysis
See how CK Life Sciences International (Holdings), Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
0775.HK●HKSE
HealthcareMedical - Pharmaceuticals
HK$0.59
HK$0.01(1.67%)
Hong Kong Market opens in 37h 8m
Advertisement
CK Life Sciences International (Holdings), Inc. (0775.HK)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCK Life Sciences International (Holdings), Inc. (0775.HK) Stock Overall Grade
CK Life Sciences International (Holdings), Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to CK Life Sciences International (Holdings), Inc.'s overall stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
CScore
43/100Key Ratios
CScore
45/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100CK Life Sciences International (Holdings), Inc. (0775.HK) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (43/100, C) highlight its stability, while Key Ratios (45/100, C) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each CK Life Sciences International (Holdings), Inc. stock grade, including financials, comparisons, and forecasts.